Robert D. Smyth

2.7k total citations
65 papers, 2.1k citations indexed

About

Robert D. Smyth is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Robert D. Smyth has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Pharmacology and 13 papers in Pharmacology. Recurrent topics in Robert D. Smyth's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmacological Effects of Natural Compounds (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). Robert D. Smyth is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Pharmacological Effects of Natural Compounds (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). Robert D. Smyth collaborates with scholars based in United States, Germany and United Kingdom. Robert D. Smyth's co-authors include H.A. Barker, Herbert Weissbach, Kenneth W. Foster, B. E. Volcani, J.N. Ladd, John I. Toohey, Rebecca M. Wilson, Donald O. Castell, G. H. Hottendorf and Donald R. Van Harken and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert D. Smyth

63 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert D. Smyth United States 20 1.0k 329 278 193 181 65 2.1k
M.C. Scrutton United Kingdom 31 2.0k 1.9× 122 0.4× 303 1.1× 364 1.9× 204 1.1× 77 4.3k
Harris H. Tallan United States 20 935 0.9× 373 1.1× 245 0.9× 67 0.3× 71 0.4× 39 2.6k
B.G. Wolthers Netherlands 32 1.5k 1.4× 287 0.9× 122 0.4× 648 3.4× 183 1.0× 132 3.7k
William N. Fishbein United States 28 1.2k 1.2× 76 0.2× 260 0.9× 280 1.5× 60 0.3× 75 2.8k
H. R. Sullivan United States 27 1.3k 1.2× 157 0.5× 692 2.5× 78 0.4× 273 1.5× 109 3.4k
W H Betts Australia 20 614 0.6× 122 0.4× 125 0.4× 187 1.0× 156 0.9× 36 2.1k
Stephen Naylor United States 46 2.7k 2.6× 161 0.5× 298 1.1× 198 1.0× 154 0.9× 207 6.3k
F. Irreverre United States 22 947 0.9× 728 2.2× 235 0.8× 124 0.6× 65 0.4× 44 2.2k
R. A. Chalmers United Kingdom 38 2.1k 2.0× 427 1.3× 92 0.3× 188 1.0× 69 0.4× 180 4.3k
John M. Wrigglesworth United Kingdom 26 1.4k 1.4× 97 0.3× 424 1.5× 224 1.2× 299 1.7× 87 2.3k

Countries citing papers authored by Robert D. Smyth

Since Specialization
Citations

This map shows the geographic impact of Robert D. Smyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Smyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Smyth more than expected).

Fields of papers citing papers by Robert D. Smyth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Smyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Smyth. The network helps show where Robert D. Smyth may publish in the future.

Co-authorship network of co-authors of Robert D. Smyth

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. Smyth. A scholar is included among the top collaborators of Robert D. Smyth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. Smyth. Robert D. Smyth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oguri, Shigeyuki, Tohru Sakakibara, T. Shimizu, et al.. (1988). Clinical Pharmacokinetics of Carboplatin. The Journal of Clinical Pharmacology. 28(3). 208–215. 92 indexed citations
2.
López, José A., et al.. (1985). Clinical pharmacology of intraperitoneal cisplatin. Gynecologic Oncology. 20(1). 1–9. 51 indexed citations
3.
Dajani, A S, M C Thirumoorthi, Roger E. Bawdon, et al.. (1982). Pharmacokinetics of intramuscular ceforanide in infants, children, and adolescents. Antimicrobial Agents and Chemotherapy. 21(2). 282–287. 9 indexed citations
4.
Gaver, Robert C., G. Michael Deeb, Kelly Pittman, & Robert D. Smyth. (1981). Disposition of anagrelide, an inhibitor of platelet aggregation. Clinical Pharmacology & Therapeutics. 29(3). 381–386. 18 indexed citations
5.
Pfeffer, Morris, et al.. (1980). Comparative Pharmacokinetics of Ceforanide (BL-S786R) and Cefazolin in Laboratory Animals and Humans. Antimicrobial Agents and Chemotherapy. 17(2). 188–192. 46 indexed citations
6.
Gaver, Robert C., et al.. (1980). Disposition of parenteral butorphanol in man.. Drug Metabolism and Disposition. 8(4). 230–235. 20 indexed citations
7.
Pittman, Kenneth A., et al.. (1980). Human perinatal distribution of butorphanol. American Journal of Obstetrics and Gynecology. 138(7). 797–800. 21 indexed citations
8.
Smyth, Robert D. & G. H. Hottendorf. (1980). Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Toxicology and Applied Pharmacology. 53(2). 179–195. 19 indexed citations
9.
Smyth, Robert D., et al.. (1980). The relationship between serum gastrin, gastric ulceration and basal acid output in the polyarthritic rat.. Journal of Pharmacology and Experimental Therapeutics. 212(2). 333–336. 7 indexed citations
10.
Smyth, Robert D., et al.. (1979). Clinical Pharmacokinetics and Safety of High Doses of Ceforanide (BL-S786R) and Cefazolin. Antimicrobial Agents and Chemotherapy. 16(5). 615–621. 31 indexed citations
11.
Smyth, Robert D., et al.. (1977). Comparative metabolism of fenclorac in rat, dog, monkey, and man.. Drug Metabolism and Disposition. 5(2). 122–131. 3 indexed citations
12.
Smyth, Robert D., et al.. (1977). Temporal pattern and reversal of impaired hepatic mono-oxygenases by phenobarbital in rats with developing and established adjuvant disease.. Journal of Pharmacology and Experimental Therapeutics. 203(1). 169–183. 11 indexed citations
13.
Smyth, Robert D., et al.. (1976). Correlation of In Vitro and In Vivo Methodology for Evaluation of Antacids. Journal of Pharmaceutical Sciences. 65(7). 1045–1047. 12 indexed citations
14.
Smyth, Robert D., et al.. (1976). Induction of hepatic enzymes by methaqualone and effect on warfarin-induced hypoprothrombinemia.. Journal of Pharmacology and Experimental Therapeutics. 196(1). 204–212. 4 indexed citations
15.
Nuss, George W., et al.. (1976). The antiphlogistic, antinociceptive and antipyretic properties of fenclorac. Inflammation Research. 6(6). 735–747. 9 indexed citations
16.
Smyth, Robert D. & Paul H. Maurer. (1972). Association of synthetic polypeptides with ribonucleic acid of immunocompetent tissues. II. Effect of optical configuration of polypeptides--in vitro and in vivo systems.. PubMed. 108(5). 1420–30. 2 indexed citations
17.
Smyth, Robert D., et al.. (1967). The mofidication of various enzyme parameters in brain acetylcholine metabolism by chronic ingestion of ethanol.. PubMed. 25(1). 1–6. 3 indexed citations
18.
Smyth, Robert D., et al.. (1964). Quercetin Inhibition of Specific Histidine Decarboxylase. Experimental Biology and Medicine. 116(3). 593–596. 3 indexed citations
19.
Barker, H.A., Robert D. Smyth, Herbert Weissbach, et al.. (1960). Assay, Purification, and Properties of the Adenylcobamide Coenzyme. Journal of Biological Chemistry. 235(1). 181–190. 157 indexed citations
20.
Ellenbogen, Leon, et al.. (1960). Inhibition of cobamide coenzyme activity by intrinsic factor. Biochemical and Biophysical Research Communications. 3(2). 178–181. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.C. Scrutton Breakdown of academic impact, for papers by Harris H. Tallan Breakdown of academic impact, for papers by B.G. Wolthers Breakdown of academic impact, for papers by William N. Fishbein Breakdown of academic impact, for papers by H. R. Sullivan Breakdown of academic impact, for papers by W H Betts Breakdown of academic impact, for papers by Stephen Naylor Breakdown of academic impact, for papers by F. Irreverre Breakdown of academic impact, for papers by R. A. Chalmers Breakdown of academic impact, for papers by John M. Wrigglesworth
Rankless by CCL
2026